Frist Cressey Ventures — 2018 Investments
2 investments dated 2018 · listed companies and verified rows first · show all
AI diagnostics company whose FDA-cleared autonomous system detects diabetic retinopathy from retinal images in primary care.
HealthtechCoralville, US
James Folk(Manager, Vice President & Secretary)Michael D Abramoff(Manager & President)Gary Seamans(Executive Officer, Director)Benjamin Clark(Chief Operating Officer & Vice President)
BoardHoward H Leach(Manager)
Board seatWilliam Frist· per SEC Form D · $32.6M raise · filed Sep 2018
Co-investors8VC
MDsave operates a healthcare marketplace where patients pre-purchase bundled medical procedures at pre-negotiated upfront prices.
HealthtechBrentwood, US
Paul Ketchel, III(Executive Officer, Director)Paul John Ketchel(Executive Officer)
BoardCalvin Magee(Director)Clyde Spencer(Director)William Frist(Director)
Board seatWilliam Harrison Frist, Sr.· per SEC Form D · $4.8M raise · filed Jun 2018
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.